These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 18221755

  • 1. Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatment.
    Pollack MH, Endicott J, Liebowitz M, Russell J, Detke M, Spann M, Ball S, Swindle R.
    J Psychiatr Res; 2008 Oct; 42(12):1042-9. PubMed ID: 18221755
    [Abstract] [Full Text] [Related]

  • 2. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C, Hartford J, Russell J, Ball S, Erickson J, Raskin J, Rynn M.
    Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Jun; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
    Russell JM, Weisberg R, Fava M, Hartford JT, Erickson JS, D'Souza DN.
    Depress Anxiety; 2008 Jun; 25(7):E1-11. PubMed ID: 17587217
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
    Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.
    Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
    [Abstract] [Full Text] [Related]

  • 6. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K, Andersen HF, Reines EH.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [Abstract] [Full Text] [Related]

  • 7. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [Abstract] [Full Text] [Related]

  • 8. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
    Nicolini H, Bakish D, Duenas H, Spann M, Erickson J, Hallberg C, Ball S, Sagman D, Russell JM.
    Psychol Med; 2009 Feb; 39(2):267-76. PubMed ID: 18485261
    [Abstract] [Full Text] [Related]

  • 9. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan 04; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 11. Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire.
    Wyrwich K, Harnam N, Revicki DA, Locklear JC, Svedsäter H, Endicott J.
    Int Clin Psychopharmacol; 2009 Nov 04; 24(6):289-95. PubMed ID: 19707153
    [Abstract] [Full Text] [Related]

  • 12. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.
    Wu WY, Wang G, Ball SG, Desaiah D, Ang QQ.
    Chin Med J (Engl); 2011 Oct 04; 124(20):3260-8. PubMed ID: 22088518
    [Abstract] [Full Text] [Related]

  • 13. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial.
    Ball S, Marangell LB, Lipsius S, Russell JM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun 03; 43():217-21. PubMed ID: 23313564
    [Abstract] [Full Text] [Related]

  • 14. Duloxetine in treatment of anxiety symptoms associated with depression.
    Dunner DL, Goldstein DJ, Mallinckrodt C, Lu Y, Detke MJ.
    Depress Anxiety; 2003 Jun 03; 18(2):53-61. PubMed ID: 12964171
    [Abstract] [Full Text] [Related]

  • 15. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A.
    Int Clin Psychopharmacol; 2011 Mar 03; 26(2):75-83. PubMed ID: 21102344
    [Abstract] [Full Text] [Related]

  • 16. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial.
    Davidson JR, Wittchen HU, Llorca PM, Erickson J, Detke M, Ball SG, Russell JM.
    Eur Neuropsychopharmacol; 2008 Sep 03; 18(9):673-81. PubMed ID: 18559291
    [Abstract] [Full Text] [Related]

  • 17. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
    Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ.
    Int J Clin Pract; 2007 Aug 03; 61(8):1337-48. PubMed ID: 17627710
    [Abstract] [Full Text] [Related]

  • 18. Duloxetine in the treatment of generalized anxiety disorder.
    Kornstein SG, Russell JM, Spann ME, Crits-Christoph P, Ball SG.
    Expert Rev Neurother; 2009 Feb 03; 9(2):155-65. PubMed ID: 19210191
    [Abstract] [Full Text] [Related]

  • 19. Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial.
    Allgulander C, Jørgensen T, Wade A, François C, Despiegel N, Auquier P, Toumi M.
    Curr Med Res Opin; 2007 Oct 03; 23(10):2543-9. PubMed ID: 17825130
    [Abstract] [Full Text] [Related]

  • 20. Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.
    Nelson JC.
    Depress Anxiety; 2010 Oct 03; 27(1):12-8. PubMed ID: 20013987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.